Social play is a highly rewarding behavior displayed mostly during the juvenile period. We recently showed that vasopressin V1a receptor (V1aR) blockade in the lateral septum (LS) enhances social play in male juvenile rats, but reduces it in females. Here, we determined whether the LS-AVP system modulates dopamine (DA) and/or norepinephrine (NE) neurotransmission in the LS to regulate social play behavior in sex-specific ways. Using microdialysis combined with retrodialysis, we demonstrated that both LS-AVP administration and social play exposure increased extracellular LS-DA release in females, but not in males. Pharmacological blockade of LS-DA receptors reduced social play in both sexes, but required a higher dose in females. This suggests that baseline LS-DA release is sufficient for social play in males, while increased LS-DA release is necessary for social play in females. Administration of a V1aR antagonist into the LS inhibited the social play-induced increase in extracellular LS-DA release in females. Furthermore, co-administration of the DA agonist apomorphine prevented the LS-V1aR blockade-induced decrease in social play in females. This suggests that LS-V1aR blockade reduces social play in females by dampening the rise in LS-DA release. Extracellular LS-NE release was enhanced in response to pharmacological manipulations of the LS-AVP system and to social play in males and/or females, but pharmacological blockade or stimulation of LS-NE receptors did not alter social play in either sex. Overall, we define a mechanism by which the LS-AVP system alters LS-DA neurotransmission differently in males than females resulting in the sex-specific regulation of juvenile social play behavior.
INTRODUCTION
Social play is a highly motivating and rewarding behavior [1, 2] that is prominently displayed during the juvenile phase in most mammalian species [3, 4] . Children diagnosed with autism spectrum disorder (ASD) show impaired social play [5] , which may be due to disrupted reward-seeking tendencies [6, 7] . Furthermore, ASD shows strong sex differences in incidence, symptoms severity, and treatment responses [8] . Overall, this indicates that research into the neurobiological underpinnings of the naturally rewarding aspects of social play and its regulation in both sexes is essential and may eventually inform therapeutic strategies.
Research on juvenile male rats suggests the involvement of dopamine (DA) and norepinephrine (NE) in the rewarding aspects of social play behavior. For example, systemic administration of drugs enhancing DA signaling increased reinforcement responding for social play, and these effects were blocked by administration of non-specific DA receptor antagonists [9] . Moreover, systemic administration of the NE reuptake inhibitor atomoxetine decreased responding for social play and decreased the expression of social play [9] . Despite a few studies using local manipulation of the DA and NE systems [10, 11] , little is known about the sites of action of DA and NE signaling in the brain involved in social play behavior. In addition, all studies thus far focused on male rats and it is unclear whether DA and NE are similarly involved in social play behavior in females.
We recently showed that social play behavior is regulated by the lateral septum (LS) in both male and female juvenile rats [12] [13] [14] . The LS receives dopaminergic input from the ventral tegmental area (VTA) and adrenergic input from the locus coeruleus [15, 16] . Electrophysiological stimulation of the VTA excites LS neurons and application of DA receptor antagonists in the LS inhibits this effect [17] . However, bath application of DA or NE reduced the firing rate of a majority of spontaneously active LS neurons [18] . Therefore, it is likely known that the effects of DA and NE in the LS are dependent on additional inputs to the LS [19] . These inputs may include vasopressinergic efferents from the bed nucleus of the stria terminalis and medial amygdala [20] [21] [22] . In support, bath application of arginine vasopressin (AVP) reduced the DA-induced or NE-induced inhibition of spontaneous LS neuronal activity [18] . This suggests that LS-AVP modulates LS-DA and LS-NE signaling. Here, we hypothesized that this modulation occurs during social play behavior.
We previously demonstrated that the LS-AVP system regulates social play behavior in sex-specific ways. Specifically, pharmacological blockade of the AVP V1a receptor (V1aR) in the LS increased social play behavior in juvenile male rats but decreased it in females [12, 13] . However, it is unclear what the underlying mechanisms are. Using in vivo microdialysis combined with retrodialysis, we determined whether LS-AVP administration, LSV1aR blockade, and social play exposure are associated with changes in extracellular LS-DA and LS-NE release in male and female juvenile rats. On the basis of these changes, we then used a pharmacological approach to determine the causal involvement of LS-DA and LS-NE neurotransmission on social play behavior.
MATERIALS AND METHODS

Animals
Male and female Wistar rats (23-day-old) were obtained from Charles River (Raleigh, NC, USA) and maintained under standard laboratory conditions (12 h light/dark cycle, lights off at 1400 hours, 22°C, 50% humidity, food and water ad libitum). Rats were housed in same-sex groups of four in standard rat cages (48 × 27 × 20 cm 3 ) unless otherwise mentioned. The experiments were conducted in accordance with the guidelines of the NIH and approved by the Institutional Animal Care and Use Committee at Michigan State University and at Boston College.
Extracellular DA and NE release in the LS of juvenile male and female rats in response to LS-AVP system manipulations and social play exposure The effect of LS-AVP administration (experiment 1), social play exposure (experiment 2), and local V1aR antagonist administration combined with social play exposure (experiment 3) on extracellular DA and NE release in the LS of 32-day-old male and female rats was determined using intracerebral microdialysis with (experiment 1 and 3) or without (experiment 2) retrodialysis. All microdialysis experiments took place in the home cage of individually housed experimental rats. At 28 days of age, experimental rats were housed individually in a standard rat cage with bedding that was not changed for the remainder of the experiments. Experimental rats were familiarized with the microdialysis setup 1 day after being housed individually. At 30 days of age, experimental rats were anesthetized with isoflurane (Butler Schein Animal Health, Dublin, OH, USA) and mounted on a stereotaxic frame (Kopf Instruments, Tujunga, CA, USA) with the tooth bar set at −4.5 mm. The u-shaped microdialysis probes (Brainlink, Groningen, The Netherlands) were unilaterally implanted into the LS according to Lukas et al. [23] at coordinates 0.4 mm caudal to bregma, −1.5 mm lateral to the midline, 5.6 mm beneath the surface of the skull at an angle of 10°to avoid damage to the sagittal sinus. The probes were filled with sterile Lactated Ringer's solution (pH 7.4) and fixed to the skull with three stainless steel screws and dental cement. Two 5-cm-long pieces of polyethylene tubing (PE 20, Plastics One, Roanoke, VA, USA) filled with Ringer's solution were connected to the inflow and the outflow of the probe and fixed with dental cement. After 1 day of surgery, probes were flushed with Ringer's and rats were familiarized with the microdialysis procedure. After 2 days of surgery, microdialysis probes were perfused with Ringer's (3.0 μl/ min, pH 7.4) using a microinfusion pump. After a stabilizing period of 2 h, 6 consecutive 10-min dialysates were collected. For experiment 1-3, dialysates 1 and 2 were taken under baseline (undisturbed) conditions. For experiment 1, dialysate 3 was taken at the end of a 10-min retrodialysis period with synthetic AVP (Sigma; 1 μg/ml; this concentration will result in~2 ng of AVP delivered locally into the LS during a 10-min retrodialysis period, based on Engelmann et al. (1992) ), and dialysates 4, 5, and 6 were taken thereafter. For experiment 2, dialysate 3 was taken at the end of the 10-min social play test, and dialysates 4, 5, and 6 were taken thereafter. For the social play test, each experimental rat was exposed to an age-matched and sex-matched socially housed unfamiliar rat for a 10-min period. For experiment 3, dialysate 3 was taken at the end of a 10-min retrodialysis period with the V1aR antagonist d(CH 2 ) 5 -(Tyr (Me) 2 )AVP [24] (10 μg/ml; this concentration will result in~20 ng of V1aR antagonist delivered locally into the LS during a 10-min retrodialysis period, based on Engelmann et al. (1992) ), dialysate 4 was taken at the end of a second 10-min retrodialysis period with the V1aR antagonist combined with 10-min social play exposure, and dialysates 5 and 6 were taken thereafter. Microdialysates were immediately frozen on dry ice and stored at −45°C. DA and NE concentrations were quantified in 10 μl dialysates by HPLC with tandem mass spectrometry (MS/MS) detection, using deuterated internal standards of the analytes (BrainsOnline, San Francisco), as described previously [25] . Rats were killed with CO 2 and proper probe placement in the LS (Fig. 1a) was checked on Nissl-stained 30 µm cryocut coronal brain sections. Rats with incorrect probe placement were removed from the analysis. The final number per group is indicated in the legends of Figs. 2 and 3. During microdialysis, the percentage of social play duration of male and female rats was 8.34 ± 1.53 and 7.27 ± 1.64 respectively, which is similar to our previous microdialysis study in juvenile rats [14] .
Effects of pharmacological manipulations of DA or NE neurotransmission in the LS on social play behavior in juvenile male and female rats To determine the causal involvement of extracellular LS-DA and LS-NE release patterns on social play behavior, various drugs that alter DA or NE neurotransmission were administered in the LS. After 5 days of daily handling to familiarize them to the injection procedure, experimental rats (30 days of age) were anesthetized with isoflurane (Butler Schein Animal Health, Dublin, OH, USA) and mounted on a stereotaxic frame with the tooth bar set at −4.5 mm. Guide cannulae (22 gauge; Plastics One, Roanoke, VA, USA) were implanted 2 mm dorsal to the medial part of the LS according to Veenema et al. [12] at coordinates 0.4 mm caudal to bregma, −1.0 mm lateral to the midline and 3.6 mm ventral to the surface of the skull at an angle of 10°from the midsagittal plane to avoid damage to the sagittal sinus. Cannulae were fixed to the skull with three stainless steel screws and dental cement and closed with a dummy cannula (Plastics One, Roanoke, VA, USA). After surgery, rats were housed individually. After 2 days, rats received a 0. [11, [26] [27] [28] [29] [30] . Behavioral testing occurred at the beginning of the dark phase (between 1400 hours and 1500 hours) and under red light conditions. Each experimental rat was exposed to an age-matched and sex-matched socially housed unfamiliar rat for a 10-min period. Tests were videotaped for subsequent analysis of behavior by a researcher blinded to the treatment conditions using JWatcher (http://www. jwatcher.ucla.edu/). Social play duration of the experimental rats was scored according to Veenema and Neumann [31] and consisted of the time spent in playful social interactions including nape attacks, pinning and supine poses. The number of nape attacks, pinning and supine poses was also scored. After the experiments, rats were euthanized with CO 2 , and charcoal was injected as a marker to check proper cannula placement ( 
Statistics
The percent of baseline DA release and NE release was analyzed using two-way ANOVAs for repeated measures (sex × dialysate). An LSD post hoc test was run when significant sex × dialysate interaction effects were found. When only a significant dialysate effect was found, a one-way ANOVA for repeated measures was run by sex to test for dialysate effects within each sex, followed by LSD post hoc testing. Absolute DA and NE concentrations were analyzed for sex effects using Student's t-tests. Drug treatment effects were analyzed using two-way ANOVAs (sex × drug) or oneway ANOVA (drug) followed by Bonferroni post hoc tests. Data are presented as mean+SEM. Significance was set at p < 0.05.
RESULTS
Sex-specific effects of AVP and social play exposure on extracellular LS-DA release in juvenile rats LS-DA release increased in females, but not in males, in response to LS-AVP treatment. The percent of baseline LS-DA release increased in response to LS-AVP administration in females but not in males (sex × dialysate effect: F (5,75) = 5.60, p < 0.001). Specifically, in females, DA release during and immediately after AVP administration was significantly higher compared to baseline (LSD post hoc: p < 0.005, dialysate 3 vs. dialysates 1 and 2; p < 0.001, dialysate 4 vs. dialysates 1 and 2; Fig. 2b ). In contrast, in males, DA release did not change in response to AVP (LSD post hoc: p > 0.63, dialysate 3 and 4 vs. dialysates 1 and 2; Fig. 2b ). Hence, females showed a greater percent of baseline LS-DA release than males during and immediately after AVP administration (LSD post hoc: p < 0.01, dialysate 3; p < 0.005, dialysate 4; Fig. 2b ). There was no sex difference in absolute extracellular DA concentrations under baseline conditions (p = 0.52, average of dialysates 1 and 2) or during AVP administration (p = 0.17, AVP = dialysate 3; Fig. 2c ). However, absolute extracellular DA concentrations were significantly higher in females than males immediately after AVP administration (p < 0.05, post-AVP = dialysate 4; Fig. 2c ).
LS-DA release increased in females, but not in males, in response to social play exposure. The percent of baseline LS-DA release increased during social play exposure in females, but not in males (sex × dialysate effect: F (5,65) = 3.19, p < 0.05). Specifically, in females, DA release during and immediately after social play exposure was significantly higher compared to all other dialysates (LSD post hoc: p < 0.05, dialysates 3 and 4 vs. dialysates 1, 2, 5, and 6; No sex difference was found for absolute extracellular NE concentrations under baseline conditions or in response to AVP administration (Fig. 3c) .
LS-NE release increased in both sexes in response to social play exposure. The percent of baseline LS-NE release increased in response to social play exposure (dialysate effect: F (5,70) = 4.92; p < 0.005). Further statistical analysis by sex confirmed this effect in Fig. 2 Sex-specific effects of vasopressin (AVP) and social play exposure on extracellular dopamine (DA) release in the lateral septum (LS) of juvenile rats. DA release was measured in the LS under baseline conditions and in response to LS-AVP retrodialysis (males n = 11, females n = 6; a-c), social play exposure (males n = 9, females n = 7; d-f), and LS-V1aR antagonist (V1aR-a) retrodialysis (males n = 6, females n = 7; g-i).
The percent of baseline DA release increased in females, but not in males, in response to AVP retrodialysis (b) and social play exposure (e), but did not change in response to V1aR antagonist retrodialysis (h). Females showed higher DA concentrations than males after AVP administration (Post-AVP = dialysate 4; c) while no sex differences were observed under baseline conditions (Baseline = mean of dialysates 1 and 2; c, f, i), during social play exposure (Play = dialysate 3) (f), or during V1aR antagonist retrodialysis (i). Data are presented as mean+SEM; Two-way ANOVA for repeated measures (sex × dialysate) followed by LSD post-hoc testing for b, e, and h; Student's t-test for c, f, i; *p < 0.05 vs. Fig. 3e ). No sex difference was found for extracellular NE Fig. 3 Extracellular norepinephrine (NE) release in the lateral septum (LS) of juvenile male and female rats increased in response to vasopressin (AVP), social play exposure and V1aR antagonist (V1aR-a) treatment. NE release was measured in the LS under baseline conditions and in response to LS-AVP retrodialysis (males n = 10, females n = 10; a-c), social play exposure (males n = 8, females n = 8; d-f), and LS-V1aR-a retrodialysis (males n = 9, females n = 8; g-i). The percent of baseline NE release increased in males and females in response to AVP retrodialysis (b), during social play exposure (e), and during V1aR antagonist retrodialysis (h). No sex differences in absolute NE concentrations were observed under baseline conditions (Baseline = mean of dialysates 1 and 2; c, f, i), but females showed higher absolute NE concentrations than males during social play exposure (Play = dialysate 3; f). Data are presented as mean+SEM; Two-way ANOVA for repeated measures (sex × dialysate) followed by one-way ANOVA for repeated measures by sex (dialysate) followed by LSD post-hoc testing for b, e, and h; Student's t-test for c, f, and i; ‡ p < 0.05, treatment effect in males, dialysate 3 vs. dialysate 2 (h) and dialysate 4 vs. dialysates 1 and 2 (b, h); *p < 0.05, treatment effect in females, dialysate 3 vs. dialysate 1 (e), dialysate 3 vs. dialysate 1 and 2 (h), dialysate 4 vs. dialysates 1 and 2 (e, h);
females vs. males (f)
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concentrations under baseline conditions. However, absolute NE concentrations were higher in females than in males during social play (p < 0.05; Fig. 3f ). Fig. 3h ) and in response to the V1aR antagonist combined with social play exposure (both sexes: p < 0.05, dialysate 4 vs. dialysates 1 and 2; Fig. 3h ). No sex difference was found for absolute NE concentrations under baseline conditions or during V1aR antagonist treatment (Fig. 3i) .
LS-NE release increased in both sexes in response to LS-
LS-DA signaling facilitates social play behavior in both sexes and plays a role in the LS-V1aR antagonist-induced decrease in social play behavior in females Rats were administered the non-specific DA receptor antagonist cis-(z)-flupenthixol into the LS to determine the causal involvement of LS-DA release in the regulation of social play. LS-DA receptor blockade decreased social play duration (Treatment effect: F (2,40) = 13.5; p < 0.001) at both doses in males (p < 0.01, 15 and 30 µg/0.5 μl vs. vehicle), while it decreased social play duration only at the higher dose in females (p < 0.005, 30 µg/0.5 μl vs. vehicle; Fig. 4a ). The same pattern was seen for the number of nape attacks (Treatment effect: F (2,40) = 13.6; p < 0.001) with LS-DA receptor blockade decreasing the number of nape attacks at both doses in males (p < 0.005, 15 and 30 µg/0.5 μl vs. vehicle), while it decreased the number of nape attacks only at the higher dose in females (p < 0.005, 30 µg/0.5 μl vs. vehicle; Table S1 ). The number of pins was also affected by LS-DA receptor blockade (Treatment effect: F (2,40) = 6.80; p < 0.005), resulting in fewer pins at the higher dose in females only (p < 0.05, 30 µg/0.5 μl vs. vehicle; Table S1 ).
To determine whether an increase in LS-DA signaling could prevent the decrease in social play behavior as previously seen in females after LS-V1aR blockade [12, 13] , females were administered the V1aR antagonist into the LS in conjunction with the DA agonist apomorphine. Administration of the V1aR antagonist into the LS decreased social play duration in females (Treatment effect: F (3,37) = 5.13; p < 0.01; Post hoc: p < 0.01, V1aR-a vs. vehicle; p < 0.05, V1aR-a vs. V1aR-a + APO0.2 and V1aR-a + APO2; Fig. 4b ), while the combined administration of the V1aR antagonist with either dose of apomorphine did not alter social play duration in females (Post hoc: p = 1.00, vehicle vs. V1aR-a + APO0.2 and V1aR-a + APO2; Fig. 4b) . A similar pattern was seen for the number of nape attacks (Treatment effect: F (2,37) = 5.18; p < 0.005) and the number of pins (Treatment effect: F (2,37) = 4.33; p < 0.05), with fewer nape attacks and fewer pins on V1aR antagonist-treated females compared with females receiving the combined treatment of V1aR antagonist and the high dose of apomorphine (nape attacks: p < 0.005; pins: p < 0.05) and compared with vehicle-treated females (pins: p < 0.05; Table S2 ).
LS-NE signaling does not regulate social play behavior in either sex Administration of the non-specific NE agonist DL-norepinephrine hydrochloride, the alpha adrenergic receptor antagonist phentolamine, or the beta adrenergic receptor antagonist propranolol into the LS did not significantly alter social play duration (Fig. 5) nor the number of nape attacks, pins, and supine poses (Table S3 , S4, S5) in males or in females. However, propranolol treatment induced a sex effect for the number of nape attacks (Sex effect: F (2,38) = 12.6; p < 0.005), with fewer nape attacks in females than in males at both doses (p < 0.05; Table S5 ).
DISCUSSION
This is the first in vivo study demonstrating that extracellular DA and NE release in the LS is modulated by the LS-AVP system and by social play exposure. Importantly, extracellular LS-DA release patterns were sex-specific as reflected by increased LS-DA release in response to LS-AVP administration and in response to social play exposure in females only. Notably, LS-V1aR blockade prevented the social play-induced increase in LS-DA release in females. Furthermore, pharmacological manipulations show that LS-DA neurotransmission facilitates social play behavior in both sexes and that enhancing LS-DA neurotransmission counteracts the inhibiting effects of LS-V1aR blockade on social play behavior in females. Finally, LS-AVP manipulations and social play exposure 2 ]AVP at 10 ng/0.5 µl (V1aR-a) reduced social play duration compared to vehicle treatment (Veh) in females, an effect that is prevented by co-administration of the DA agonist apomorphine at 2 µg/0.5 µl (APO2) but not at 0.2 µg/0.5 µl (APO0.2). Data are presented as mean + SEM; Two-way ANOVA (sex × treatment; a) or one-way ANOVA (treatment; b) followed by Bonferroni post-hoc testing. a *p < 0.05 vs. vehicle; b *p < 0.05 vs. vehicle, V1aR-a + APO0.2, and V1aR-a + APO2.0
Involvement of dopamine, but not norepinephrine, in the sex-specific…increased LS-NE release in males and/or females, but pharmacological manipulations of LS-NE neurotransmission did not alter social play duration in either sex. Altogether, these findings demonstrate a critical role for LS-DA, but not LS-NE, neurotransmission in the sex-specific regulation of social play behavior by the LS-AVP system. Enhanced LS-DA release in response to LS-AVP administration or social play exposure in females Although extracellular LS-DA release was similar between the sexes under baseline conditions, an increase in the percent of baseline LS-DA release in response to LS-AVP administration or social play exposure was seen in females only. Increased extracellular LS-DA release has been observed in response to systemic application of drugs of abuse such as cocaine in rats and morphine in mice [32, 33] , suggesting a role for LS-DA neurotransmission in the positive and reinforcing effects of drug taking. This corresponds with other studies indicating that the LS is part of the brain reward system. For example, the LS is associated with electrical self-stimulation in rats and humans [34, 35] and is necessary for the formation of cocaine conditioned place preference in rats [36, 37] . Importantly, the abovementioned studies used adult males and exposed them to nonsocial rewards. Our findings are the first to reveal a sex-specific pattern of LS-DA release during exposure to a social reward. This seems in line with a recent study showing increased Fos-activation of VTA-DA neurons in female, but not male, juvenile rats following social play exposure [38] . Together, these findings point towards distinct neural circuitries involved in social play and suggest a role for enhanced LS-DA neurotransmission in the rewarding aspects of social play behavior in females only.
LS-V1aR antagonist treatment prevents increase in LS-DA release in females
We further demonstrate that LS-V1aR blockade eliminates the sex difference in the percent of baseline in extracellular LS-DA release during social play exposure. Specifically, LS-V1aR antagonist administration did not induce a significant change in extracellular LS-DA release under baseline conditions in either sex and prevented the increase in LS-DA release seen in females exposed to social play. Moreover, enhancing LS-DA signaling by local administration of the DA agonist apomorphine prevented the decrease in social play behavior induced by LS-V1aR blockade in females. Together, this suggests that LS-V1aR antagonist reduces social play behavior in females by dampening the social playinduced rise in LS-DA release.
The mechanism by which the LS-AVP system modulates LS-DA release in females is presently unclear. Male and female rats show very dense V1aR binding in the dorsal and intermediate LS, with females having even denser binding than males [39, 40] . Some evidence in adult male mice suggests that a portion of V1aR is located on terminals of dopaminergic neurons innervating the LS [41] . In detail, treatment with 6-hydroxydopamine, a neurotoxin that selectively destroys DA and NE neurons in the brain, reduced LS-DA and LS-NE concentrations as well as LS-AVP binding [41] . Importantly, treatment with 6-hydroxydopamine combined with the highly specific NE reuptake inhibitor desmethylimipramine, that prevents 6-hydroxydopamine to destroy NE neurons, reduced LS-DA concentrations as well as LS-AVP binding [41] . Thus, AVPinduced activation of LS-V1aR presynaptically located on dopaminergic terminals may be one plausible mechanism to explain the AVP-induced increase in LS-DA release as well as how LS-V1aR antagonist treatment could prevent the social play-induced increase in LS-DA release in juvenile female rats.
Lack of change in LS-DA release in response to LS-AVP administration or social play exposure in males It may be surprising that no increase in LS-DA release was observed in males in response to LS-AVP administration or social play exposure. However, it is possible that fast and short increases in LS-DA release have been missed during the 10-min sampling time. Alternatively, baseline LS-DA release may be sufficient for social play in males. In support the non-specific DA receptor antagonist cis-(z)-flupenthixol decreased social play in males at a lower dose (15 μg/0.5 μl) compared to females (30 μg/0.5 μl). Thus, Fig. 5 No effects of manipulations of the norepinephrine (NE) system in the lateral septum on social play behavior in male and female juvenile rats. a Administration of NE at either the lower dose (10 nmol/0.5 µl Ringer's; NE10) or higher dose (30 nmol/0.5 µl Ringer's; NE30) did not significantly alter social play duration compared to vehicle treatment (Veh) in males and females. b Administration of the alpha adrenergic receptor antagonist phentolalamine at either the lower dose (1 µg/0.5 µl Ringer's) or higher dose (5 µg/0.5 µl Ringer's) did not significantly alter social play duration compared to vehicle treatment (Veh) in males and females. c Administration of the beta adrenergic receptor antagonist propranolol at either the lower dose (2 µg/0.5 µl Ringer's) or higher dose (5 µg/0.5 µl Ringer's) did not significantly alter social play duration compared to vehicle treatment (Veh) in males and females. Data are presented as mean+SEM; Two-way ANOVA (sex × treatment)
Involvement of dopamine, but not norepinephrine, in the sex-specific…along with the sex-specific regulation of social play behavior by the LS-AVP and LS-glutamate systems [12] [13] [14] , the observed sex difference in social play-induced LS-DA release, may be another indicator that social play behavior is regulated by distinct neural circuitries in males compared to females.
DA neurotransmission in the nucleus accumbens was also found to modulate social play behavior. Here, administration of a D1 receptor antagonist, a D2 receptor antagonist, or the non-specific DA receptor antagonist alpha-flupenthixol reduced social play behavior in juvenile male rats (females were not tested [11] ). This indicates that DA acting at multiple brain sites is involved in the regulation of social play behavior. Interestingly, the nucleus accumbens and the LS share some of the same dopaminergic fibers originating from the VTA [16, 17] . Thus, it is plausible that social play exposure triggers activation of VTA-DA neurons projecting to both the LS and nucleus accumbens. If so, we hypothesize that the social play-induced sex difference in extracellular DA release pattern as observed in the LS may also be present in the nucleus accumbens. Future studies may want to test this hypothesis that could provide further evidence of a sex-specific neural circuitry regulating the reinforcing properties of social play behavior.
No effect of LS-NE neurotransmission on social play behavior in either sex Although extracellular LS-NE release increased following LS-AVP administration (males), LS-V1aR antagonist administration (both sexes), and social play exposure (females), pharmacological manipulations to enhance or reduce LS-NE signaling did not significantly alter social play duration in either sex. Despite the use of multiple drug doses, it cannot be excluded that additional drug doses or different types of drugs might alter social play duration. Indeed, enhancing NE signaling by using NE reuptake inhibitors reduced social play in juvenile male rats (females were not tested) when administered into other brain regions such as the basolateral amygdala and habenula [10] . Alternatively, the observed changes in extracellular LS-NE release may affect processes or behaviors that are relevant in the context of social play, a hypothesis that could be tested in future studies. Overall, the current findings suggest that NE neurotransmission in the LS does not play a major role in the regulation of social play behavior.
CONCLUSIONS Here, we demonstrate that LS-DA, but not LS-NE, neurotransmission is involved in the sex-specific regulation of social play behavior by the LS-AVP system. These findings have broader significance. First, they provide further evidence of sex differences in the LS neural circuitry mediating a socially rewarding behavior. It would therefore be of interest to determine whether similar sex differences occur in the LS neural circuitry mediating other social and rewarding behaviors. Second, as discussed above, the sexspecific facilitation of extracellular DA release by social play exposure may not be limited to the LS because of VTA-DA collaterals projecting to both the LS and the nucleus accumbens [16, 17] . Third, the sex-specific regulation of social play combined with the sex-specific facilitation of LS-DA release by LS-AVP provides new insights into the potential function of the sexually dimorphic extrahypothalamic AVP system, which is one of the most conserved sex differences in the brain of vertebrates [42, 43] . Last, elucidating the neural mechanisms mediating the sexspecific regulation of social reward in juveniles is an important step towards better understanding the neural basis of sex-biased social disorders such as ASD.
